Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
Conditions
- ALK Gene Mutation
- BRAF Gene Mutation
- EGFR Gene Mutation
- Head and Neck Squamous Cell Carcinoma
- Metastatic Head and Neck Carcinoma
- Recurrent Head and Neck Carcinoma
- Recurrent Non-Small Cell Lung Carcinoma
- ROS1 Gene Mutation
- Stage III Non-Small Cell Lung Cancer
- Stage IIIA Non-Small Cell Lung Cancer
- Stage IIIB Non-Small Cell Lung Cancer
- Stage IV Non-Small Cell Lung Cancer
Interventions
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Pembrolizumab
- BIOLOGICAL: Recombinant EphB4-HSA Fusion Protein
Sponsor
University of Southern California
Collaborators